Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Please indicate which comment is of concern and why. Your comments will be sent to our moderator for review.

Report comment to moderator

MandatoryRequired fields.


Why we need to talk about sex and clinical trials


Very useful article. The comment about lack of requirements for use animals of both sexes for trials in the UK in disappointing, but UK pharmacologists know all about this need. In August 2019,The British Journal of Pharmacology announced that it would not accept research manuscripts unless researchers addressed potential sex differences in their work. This applies to human, animal and tissue studies. It is time for Pharmacy journals to move in the same direction. These differences matter. In the Covid-19 pandemic, soon if not already, the number of men dying will exceed women by hundreds of thousands. Differences in immunological responses have already been noted and identified as a cause. We need to find out much more about this because it will have safety and efficacy implications for any future vaccinations (alone or alongside flu vaccination) and may influence duration of immunity after infection. And finally, in 2011 the National Association of Women Pharmacists called for the clinical trials improvements described, at a joint meeting with the Medical Women's Federation and RPS: 'Blue Pill Pink Pill.' The Lancet followed up the call in it's editorial the next week. The PJ did not even report the meeting.

Posted date

30 MAY 2020

Posted time



Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.